This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Battegay, M Articles by Zinkernagel, R M Search for Related Content PubMed PubMed Citation Articles by Battegay, M Articles by Zinkernagel, R M

 Previous Article  |  Next Article 

J Virol. 1992 February; 66(2): 1199-1201

Vaccination with a synthetic peptide modulates lymphocytic choriomeningitis virus-mediated immunopathology.

Department of Experimental Pathology, University Hospital Zurich, Switzerland.

ABSTRACT

Vaccination with a nucleopeptide (NP 118; amino acids 118 to 132) representing a cytotoxic T-cell epitope of lymphocytic choriomeningitis virus (LCMV) can modulate immunopathology. Immunization with NP 118 protected H-2d mice against intracerebral infection with the LCMV-ARMSTRONG isolate. However, when NP 118-primed H-2d mice were challenged intracerebrally with an intermediate dose (5 x 10(4) PFU) of the LCMV-DOCILE strain, all mice primed with NP 118 emulsified in incomplete Freund's adjuvant died, whereas unprimed mice survived. Correspondingly, peptide vaccination enhanced specifically the cytotoxic T-cell response, influencing the critical balance between T-cell response and virus spread.

This article has been cited by other articles:

• Botten, J., Whitton, J. L., Barrowman, P., Sidney, J., Whitmire, J. K., Alexander, J., Ting, J. P. C., Bui, H.-H., Sette, A., Buchmeier, M. J. (2007). HLA-A2-Restricted Protection against Lethal Lymphocytic Choriomeningitis. J. Virol. 81: 2307-2317 [Abstract] [Full Text]  
• Desmézières, E., Jacob, Y., Saron, M.-F., Delpeyroux, F., Tordo, N., Perrin, P. (1999). Lyssavirus glycoproteins expressing immunologically potent foreign B cell and cytotoxic T lymphocyte epitopes as prototypes for multivalent vaccines. J. Gen. Virol. 80: 2343-2351 [Abstract] [Full Text]  
• Moskophidis, D., Kioussis, D. (1998). Contribution of  Virus-specific CD8+ Cytotoxic T Cells to Virus Clearance or Pathologic Manifestations of Influenza Virus Infection in a T Cell Receptor Transgenic Mouse Model. J. Exp. Med. 188: 223-232 [Abstract] [Full Text]  
• Ciupitu, A.-M. T., Petersson, M., O'Donnell, C. L., Williams, K., Jindal, S., Kiessling, R., Welsh, R. M. (1998). Immunization with a Lymphocytic Choriomeningitis Virus Peptide Mixed with Heat Shock Protein 70 Results in Protective Antiviral Immunity and Specific Cytotoxic T Lymphocytes. J. Exp. Med. 187: 685-691 [Abstract] [Full Text]  
• Zaghouani, H, Steinman, R, Nonacs, R, Shah, H, Gerhard, W, Bona, C (1993). Presentation of a viral T cell epitope expressed in the CDR3 region of a self immunoglobulin molecule. Science 259: 224-227 [Abstract]